Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 ...

Sleep is often a huge challenge for many people, and in several cases, people do need some sort of medical intervention.

The Centers for Medicare & Medicaid Services confirmed to CNBC that Medicare drug plans can now cover Eli Lilly’s (LLY) obesity drug ...

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on January 13.Stay Ahead of the ...

Standard treatment of this chronic ... When Lilly posted preliminary data from the sleep apnea studies in April, the stock prices of companies such as Inspire Medical Systems, which makes CPAP ...

The company develops minimally invasive solutions for patients with obstructive sleep apnea ... expand Inspire’s total addressable market by causing more people with obesity to seek treatment ...

Inspire is a medical technology ... of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. For additional information about Inspire, please ...